Cited by 208Liver Disease and TransplantationOrgan Transplantation Techniques and OutcomesNutrition and Health in Aging

A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: a competing risk analysis in a national cohort

Open access
van Vugt, Jeroen Laurens Ad, Alferink, Louise Johanna Maria, Buettner, Stefan, Gaspersz, Marcia Patricia, Bot, Daphne, Darwish Murad, Sarwa, Feshtali, Shirin, van Ooijen, Peter Martinus Adranius +6 more·2018·Journal of Hepatology

Abstract

Background & aims Frail patients with low model for end-stage liver disease (MELD) scores may be under-prioritised. Low skeletal muscle mass, namely sarcopenia, has been identified as a risk factor for waiting list mortality. A recent study proposed incorporating sarcopenia in the MELD score (MELD-Sarcopenia score). We aimed to investigate the association between sarcopenia and waiting list mortality, and to validate the MELD-Sarcopenia score (i.e. MELD + 10.35 * Sarcopenia).Methods We identified consecutive patients with cirrhosis listed for liver transplantation in the Eurotransplant registry between 2007-2014 and measured skeletal muscle mass on computed tomography. A competing risk analysis was used to compare survival of patients with and without sarcopenia, and concordance (c) indices were calculated to assess performance of the MELD and MELD-Sarcopenia score. We created a nomogram of the best predictive model.Results We included 585 patients with a median MELD score of 14 (interquartile range 9-19), of which 254 (43.4%) were identified as having sarcopenia. Median waiting list survival was shorter in patients with sarcopenia than those without (p <0.001). This effect was even more pronounced in patients with MELD ≤15. The discriminative performance of the MELD-Sarcopenia score (c-index 0.820) for three-month mortality was lower than MELD score alone (c-index 0.839). Apart from sarcopenia and MELD score, other predictive variables were occurrence of hepatic encephalopathy before listing and recipient age. A model including all these variables yielded a c-index of 0.851.Conclusions Sarcopenia was associated with waiting list mortality in liver transplant candidates with cirrhosis, particularly in patients with lower MELD scores. The MELD-Sarcopenia score was successfully validated in this cohort. However, incorporating sarcopenia in the MELD score had limited added value in predicting waiting list mortality.Lay summary In this study among patients with liver cirrhosis listed for liver transplantation, low skeletal muscle mass was associated with mortality on the waiting list, particularly in patients who were listed with low priority based on a low MELD score. However, adding these measurements to the currently used system for donor and organ allocation showed no added value.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2017.11.030

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Sarcopenia affects 50-60% of individuals with cirrhosis awaiting liver transplantation and is associated with higher rates of wait-list complications, morbidity, and mortality.

    “Sarcopenia affects 50-60% of individuals 447 and is associated with higher rates of wait-list complications, morbidity, and mortality.”

    From EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). (2024) · cites this paper as [448]

    The Patients section (page unavailable) reports sarcopenia in 43.4% or 45.5% of the cohort, depending on the definition—not 50–60%. It also reports more liver-related complications before wait-list placement, rather than complications arising on the wait-list. The waiting-list mortality section (page unavailable) supports higher mortality for one sarcopenia definition, but not the other; a separate morbidity outcome is not established. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 38 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Rutten IJ, Ubachs J, Kruitwagen RFPM, Beets-Tan RGH, Olde Damink SWM, van Gorp T. Abstracts of the 9th International Conference on Cachexia, Sarcopenia, and Muscle Wasting, Berlin, Germany, 10-11 December 2016 (part 2) (1-45: Psoas muscle measurements are inferior to total skeletal muscle measurements in the assessment of sarcopenia in ovarian cancer). J Cachexia Sarcopenia Muscle 2017;8:161-183.

Cited by

Sorted by citations

Authors
van Vugt, J. L. A., Alferink, L. J. M., Buettner, S., Gaspersz, M. P., Bot, D., Darwish Murad, S., Feshtali, S., van Ooijen, P. M. A., Polak, W. G., Porte, R. J., van Hoek, B., van den Berg, A. P., Metselaar, H. J., & IJzermans, J. N. M.
Affiliations
  • Erasmus MC (NL)
  • Leiden University Medical Center (NL)
  • University Medical Center Groningen (NL)
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2018-04
Volume
68
Issue
4
Pages
707-714
ISSN
0168-8278 (ISSN-L)
OpenAlex
W2772086822
Cited by
208
References
38
Citations by year
2026: 6 · 2025: 16 · 2024: 25 · 2023: 32 · 2022: 31 · 2021: 31 · 2020: 22 · 2019: 31 · 2018: 13
FWCI
11.12
Type
journal article
Language
en
Open access
Locations
  • Journal of Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, other-oa)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Funders
Universiteit Leiden
Topics
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
Keywords
sarcopenia, liver cirrhosis, liver transplantation, waitlist mortality, MELD score, frailty, skeletal muscle mass, hepatic encephalopathy, nomogram, competing risk analysis, recipient age
MeSH terms
Female, Humans, Liver Cirrhosis, Male, Middle Aged, Risk, Severity of Illness Index, Waiting Lists, Cohort Studies, Liver Transplantation, Sarcopenia, End Stage Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review